Research Article

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

Table 3

Incidence rate for cancer in HIV-infected persons.

30 years30–59 years60 yearsTotal

AIDS-defining cancer
 Kaposi’s sarcoma
  Male168.2 (87.5, 323.3)106.6 (89.3, 127.3)37.7 (14.1, 100.4)103.5 (67.5, 122.6)
  Female114.5 (28.6, 456.4)7.3 (1.8, 29.4)0 (0, 3.7)12.9 (4.8, 34.3)
  Both154.9 (85.8, 279.7)87.5 (73.4, 104.4)31.4 (11.8, 83.7)86.1 (72.9, 101.6)
 Non-Hodgkin’s lymphoma
  Male94.5 (38.9, 224.5)122.4 (103.7, 144.4)103.6 (57.4, 187.1)119.6 (102.3, 140.0)
  Female0 (0, 3.7)84.4 (56.1, 127.0)142.1 (45.8, 440.6)83.6 (56.9, 122.8)
  Both70.4 (29.3, 169.1)115.1 (98.7, 134.2)110.0 (65.2, 185.8)112.7 (97.5, 130.3)
Non-AIDS-defining cancer
 Colon/rectum
  Male0 (0, 3.7)39.3 (29.4, 52.7)103.6 (57.4, 187.1)43.0 (33.1, 55.8)
  Female0 (0, 3.7)18.4 (7.6, 44.1)47.4 (6.7, 336.3)19.3 (8.7, 42.9)
  Both0 (0, 3.7)35.3 (26.8, 45.6)94.3 (53.6, 166.0)38.4 (29.9, 49.2)
 Anus
  Male18.7 (2.6, 132.7)94.4 (78.2, 114.0)122.5 (71.1, 210.9)93.6 (78.4, 111.7)
  Female0 (0, 3.7)44.0 (25.0, 77.6)94.7 (23.7, 378.8)45.0 (26.7, 76.0)
  Both14.1 (2.0, 100.0)84.7 (70.8, 101.3)117.9 (71.1, 195.5)84.2 (71.2, 99.6)
 Lung, bronchus
  Male0 (0, 3.7)32.3 (23.4, 44.6)131.9 (78.12, 222.7)39.1 (29.7, 51.5)
  Female0 (0, 3.7)36.7 (19.7, 68.2)94.7 (23.7, 278.8)38.6 (21.9, 67.9)
  Both0 (0, 3.7)33.2 (24.9, 44.2)125.7 (77.0, 205.2)39.0 (30.5, 49.9)
 Prostate0 (0, 3.7)54.2 (42.2, 69.5)537.0 (414.2, 696.1)91.3 (76.3, 109.2)
 Hodgkin’s lymphoma
  Male74.8 (28.1, 199.2)40.2 (30.1, 53.7)28.3 (9.1, 87.6)40.6 (31.1, 53.2)
  Female0 (0, 3.7)14.7 (5.5, 39.1)0 (0, 3.7)12.9 (4.8, 34.3)
  Both56.3 (21.1, 150.1)35.3 (26.8, 46.6)33.6 (7.6, 73.1)35.3 (27.2, 45.8)